CIK 0001806310
- Non-accelerated filer
- Smaller reporting company
Taysha Gene Therapies, Inc.
Sign in to watch- Ticker
- TSHA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 843199512
- Phone
- +1 214-612-0000
- Business address
- 3000 PEGASUS PARK DRIVE, SUITE 1430, DALLAS, TX, 75247
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-05-30 | Manning Paul B 10% owner | Purchase | +750,000 | $2.75 | $2.1M | 2,841,704 |
| 2024-06-27 | Manning Paul B 10% owner | Purchase | +1,333,333 | $2.25 | $3.0M | 1,333,333 |
| 2023-11-17 | Manning Paul B 10% owner | Purchase | +100,000 | $1.63 | $163K | 16,566,667 |
| 2023-08-16 | Manning Paul B 10% owner | Purchase | +16,466,667 | $0.90 | $14.8M | 16,466,667 |
| 2022-10-31 | Manning Paul B Director | Purchase | +1,500,000 | $2.00 | $3.0M | 1,642,202 |
| 2022-06-17 | Manning Paul B Director | Grant or award · Stock Option (right to buy) | +15,500 | 15,500 | ||
| 2022-02-03 | Manning Paul B Director | Purchase | +50,000 | $7.84 | $392K | 142,202 |
| 2022-02-03 | Manning Paul B Director | Purchase | +26,602 | $7.84 | $209K | 2,091,704 |
| 2022-02-02 | Manning Paul B Director | Purchase | +58,000 | $7.77 | $451K | 92,202 |
| 2022-02-02 | Manning Paul B Director | Purchase | +45,000 | $7.77 | $350K | 2,065,102 |
| 2022-02-02 | Manning Paul B Director | Purchase | +22,000 | $7.77 | $171K | 22,000 |
| 2021-11-24 | Manning Paul B Director | Purchase | +2,202 | $13.19 | $29K | 34,202 |
| 2021-11-23 | Manning Paul B Director | Purchase | +20,000 | $12.54 | $251K | 32,000 |
| 2021-06-17 | Manning Paul B Director | Grant or award · Stock Option (right to buy) | +15,500 | 15,500 | ||
| 2021-05-14 | Manning Paul B Director | Purchase | +12,000 | $20.98 | $252K | 12,000 |
| 2020-09-28 | Manning Paul B Director | Conversion | +3,275,205 | 3,275,205 | ||
| 2020-09-28 | Manning Paul B Director | Conversion | +2,008,158 | 2,008,158 | ||
| 2020-09-28 | Manning Paul B Director | Conversion | +11,944 | 2,020,102 | ||
| 2020-09-28 | Manning Paul B Director | Conversion · Series A Preferred Stock | −3,006,155 | 0 | ||
| 2020-09-28 | Manning Paul B Director | Conversion · Series A Preferred Stock | −1,843,193 | 0 |
Page 1 of 2 · 22 trades